Watson Amazed by Radcliffes Steamy Shots ( Harry Potter star Emma Watson was amaze...)

Watson Amazed by Radcliffes Steamy Shots

Harry Potter star Emma Watson was amazed to see steamy shots of co-star Daniel Radcliffe in an American magazine.

Watson was surprised that she realised how handsome Radcliffe is, after looking at the shots.

I saw that and I was like, 'Hey'... (It's) the first time I've really thought, 'Ooh, wow, actually he's pretty good looking, Contactmusic quoted her, as saying.

However, she said that she doesnt fantasize about the Brit star.

"I know it sounds harsh but... no," she added.

The 17-year-old also revealed that she was hoping that she too would get the chance to drop her nice girl image by shedding her clothes especially after seeing Radcliffes performance in Equus.

Page: 1
Related medicine news :

1. FDA approves Watson Pharmaceuticals Oxytrol patch
2. Pravastatin Launched by Watson Pharmaceuticals
3. Flu Shots Best for Protection
4. The Efficacy Of Allergy Shots Questioned
5. Flu Shots Not Mandatory For Nurses
6. Britain Toddlers To Receive Flu-Jab In Addition To The 21 Shots
7. Immune Response To Flu Shots Influenced By Bereavement And Marital Status
8. Nurses Required to Wear Masks or Get Their Flu Shots
9. Only Modest Benefit of Flu Shots Among Older Adults
10. Allergy Shots May Soon be a Thing of the Past.
11. Vitamin Shots to Combat MS Pain

Post Your Comments:

(Date:12/6/2009)... ORLEANS, Dec. 6 Sickle cell disease, ... blood cells, is one of the most common ... the world, including more than 70,000 Americans.(1) Research ... the American Society of Hematology highlights intriguing studies ... presents for children with this blood disorder, evaluations ...

(Date:12/6/2009)... Treatment site www.sleeping-with-a-sleeping-disorder.com is asking people ... natural sleep aids from around the world to ... cause. The submissions will be compiled in an ... YOU, to be sold from the website in ... of the proceeds ,from sales of the E-book ...

(Date:12/5/2009)... NEW ORLEANSA new three-drug combination has shown in a ... "highly effective regimen" in the treatment of patients newly ... cells in bone marrow, say researchers from Dana-Farber Cancer ... all of the 66 patients treated with the drug ... a "very good partial response rate" in the phase ...

(Date:12/5/2009)... The first Football,for Hope Centre in Khayelitsha in ... (5 December 2009). FIFA President Joseph S. Blatter ... FIFA World Cup Organising Committee,South Africa (OC) CEO ... and Executive Mayor of the City of Cape ...

(Date:12/5/2009)... , , SATURDAY, Dec. 5 (HealthDay News) -- They,re not ... bad reactions to certain holiday traditions and need to ... to the American College of Allergy, Asthma and Immunology ... may choose to decorate with artificial plants, but both ...

[0] Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease [0] Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You [0] Multiple myeloma patients experience high response rate with new 3-drug combination [0] Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha [0] Keep Asthma, Allergies at Bay for the Holidays

... most common reason for hospitalizations, analysis finds , , WEDNESDAY, ... 1.2 million Americans -- roughly equivalent to the population ... government analysis of hospital admissions and costs found. , ... common reason for admission to hospital, and treating these ...

... Pa., July 2 David Belkin died,last February during a ... he is alive to tell about it., On Sunday, ... his hero.,He,ll present Matlaga with the Sudden Cardiac Arrest (SCA) ... Henry Skier, at,13 Hillcrest Rd. (behind Wayne Memorial Hospital) in ...

... and Georgia Reach Statewide Olmstead,Settlement Agreement, WASHINGTON, ... currently institutionalized in Georgia,s,eight public psychiatric hospitals and ... in their communities with appropriate supports,tailored to meet ... settlement,agreement between the state of Georgia and the ...

... to the gym, take simple steps to avoid the ... -- Before heading to the gym, you should brush ... deadly superbug, say doctors from Loyola University. , While ... hospitals and health-care settings, they are on the rise ...

... Medicare Advantage face significant funding cuts under legislation ... by America,s Health,Insurance Plans., As Congress considers ... in Medicare, many are looking at the Medicare ... being considered (H.R. 6331) would,cut $143 million from ...

... 2 New Hampshire seniors,enrolled in Medicare Advantage ... Congress, according to new data released by,America,s Health ... halt the impending cut to physician,payments in Medicare, ... to,pay for the fix. Legislation currently being considered ...

Other Medicine News:Health News:Back From the Dead: Cardiac Arrest Victim Salutes His Rescuer 2 Health News:Georgia to Offer More Community Living Alternatives for Individuals With Disabilities 2 Health News:Georgia to Offer More Community Living Alternatives for Individuals With Disabilities 3 Health News:MRSA Infections Can Bug Fitness Buffs 2 Health News:Proposed Congressional Legislation Would Cut $143 Million from the Medicare Advantage Program in Georgia 2 Health News:Proposed Congressional Legislation Would Cut $6.6 Million from the Medicare Advantage Program in New Hampshire 2

Lung Infections Cost Hospitals More Than $10B in 2006 Back From the Dead: Cardiac Arrest Victim Salutes His Rescuer Georgia to Offer More Community Living Alternatives for Individuals With Disabilities MRSA Infections Can Bug Fitness Buffs Proposed Congressional Legislation Would Cut $143 Million from the Medicare Advantage Program in Georgia Proposed Congressional Legislation Would Cut $6.6 Million from the Medicare Advantage Program in New Hampshire

(Date:12/4/2009)... Suneva Medical, a privately-held aesthetic medical device company, ... President and Chief Financial Officer. In this role, ... administrative functions including finance, accounting, IT, IR, administration and ... Company,s senior management team. ,, "One of my ...

(Date:12/4/2009)... Shore and E. David Crawford presented results for prostate-specific ... end points of biochemical recurrence rate in a Phase ... or monthly leuprolide in prostate cancer patients during the ... received FIRMAGON 240/80 mg/month had a recurrence rate of ...

(Date:12/3/2009)... a subsidiary of Hill-Rom Holdings, Inc. (NYSE: ... Allen Amatech(TM) OEM (Original Equipment Manufacturer) business website ... the Allen Amatech(TM) brand identity and includes an online ... and design specifications for the products. "We hope to ...

Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2 Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3 Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4 Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2 Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3 Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4 Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2 Angelica Corporation Raises Bar Again for Increased Patient Safety 48022 1 Angelica Corporation Raises Bar Again for Increased Patient Safety 48022 2 Univisions Doctora Aliza Launches VidaySalud com 28TM 29 48017 1 Univisions Doctora Aliza Launches VidaySalud com 28TM 29 48017 2 Ortho Biotech Oncology Research 26 Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 48014 1 Ortho Biotech Oncology Research 26 Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 48014 2 Ortho Biotech Oncology Research 26 Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 48014 3 Ortho Biotech Oncology Research 26 Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 48014 4

[0] Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer [0] Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial [0] Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website

... ALISO VIEJO, Calif.--(BUSINESS WIRE)--Jun 8, 2007 ... presentation of,Phase III data, including efficacy, ... patients with diabetic peripheral,neuropathic (DPN) pain ... (DM/Q)), an NMDA receptor,antagonist and sigma-1 ...

... Data presented at Movement Disorder Society’s 11th,International ... early,Parkinson’s disease patients is a critical unmet ... – Merck Serono S.A.,(virt-x: SEO) and its ... data, which suggest that safinamide, a new,agent ...

Other Medicine Technology:AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 2 AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 3 AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 4 AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 5 AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 6 AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 7 Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease 2 Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease 3 Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease 4 Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease 5 Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease 6 Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease 7

AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease

... EpochXP Workstations provide comprehensive neurological monitoring ... care unit to accurately access your ... over 15 years experience, and a ... EpochXP neurological monitoring systems have a ...

... powerful, multi-modality system capable of performing EP (including ... and train of four testing tests simultaneously. The ... The base weighs only 4.25 lbs. A complete ... desktop PC-based system with a custom cart can ...

... neuromonitoring system especially designed for surgical monitoring ... 16 channels and is equipped with two ... channel can be independently configured as either ... channel. Endeavor amplifiers are based on the ...

... Katena Products, Inc. is the ... dedicated exclusively to ophthalmic surgical ... to over 7,000 customers in ... a global network of distributors, ...

Medicine Products:

EpochXP Neurological Workstation Cascade Bravo Endeavor Harms Trabeculotomy Probe, right

( Harry Potter star Emma Watson was amaze...)Watson Amazed by Radcliffes Steamy Shots,Health